GGrantIndex
← Leaderboards

Yongjian Liu

Washington University

$10,408,809
Attributed
$13,238,685
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,238,685 · 6

By mechanism

R01$6,235,517 · 3
R35$5,098,342 · 1
P41$1,904,826 · 2

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Detection

Research focus

DetectionMonocyteInflammatoryChemokineImagePositron-Emission TomographyCellsChemokine ReceptorTracerIn VivoSpecificityBindingSensitivity And SpecificityPeptidesImaging AgentTreatment ResponseBiologyRadiotracerTissuesImmuneGrantMacrophageRadiolabeledAnimal Model

Grant awards (28)

Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$725,673
R35 · FY2025 · HL · contact PI
Imaging macrophage subset dynamics in inflammation$242,585
P41 · FY2025 · EB · contact PI
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$712,545
R35 · FY2024 · HL · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$252,589
R01 · FY2024 · CA
Imaging macrophage subset dynamics in inflammation$238,270
P41 · FY2024 · EB · contact PI
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$728,217
R35 · FY2023 · HL · contact PI
Imaging macrophage subset dynamics in inflammation$238,270
P41 · FY2023 · EB · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$168,482
R01 · FY2023 · CA
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$728,645
R35 · FY2022 · HL · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$591,868
R01 · FY2022 · CA
Imaging of Chemokine Receptors$261,097
P41 · FY2022 · EB · contact PI
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$730,246
R35 · FY2021 · HL · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$597,298
R01 · FY2021 · CA
Imaging of Chemokine Receptors$257,332
P41 · FY2021 · EB · contact PI
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$730,357
R35 · FY2020 · HL · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$580,914
R01 · FY2020 · CA
Imaging of Chemokine Receptors$236,229
P41 · FY2020 · EB · contact PI
Targeted Molecular Probes for Atherosclerosis Imaging and Therapy$742,659
R35 · FY2019 · HL · contact PI
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy$575,716
R01 · FY2019 · CA
Imaging of Chemokine Receptors$240,555
P41 · FY2019 · EB · contact PI
PET IMAGING CCR2 IN LUNG INFLAMMATION$658,214
R01 · FY2018 · HL
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSIS$369,717
R01 · FY2018 · HL · contact PI
Imaging of Chemokine Receptors$190,488
P41 · FY2018 · EB · contact PI
PET IMAGING CCR2 IN LUNG INFLAMMATION$663,070
R01 · FY2017 · HL
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSIS$370,789
R01 · FY2017 · HL · contact PI
PET IMAGING CCR2 IN LUNG INFLAMMATION$649,313
R01 · FY2016 · HL
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSIS$371,767
R01 · FY2016 · HL · contact PI
CHEMOKINE RECEPTORS BASED NANOAGENTS IMAGING ATHEROSCLEROSIS$385,780
R01 · FY2015 · HL · contact PI